NLRP3 and Huntington disease: Moreover, we further demonstrated that long-term treatment of HD mice with an NLRP3 inhibitor (MCC950) not only reduced the activation of NLRP3 and ROS production, but also rescued neuronal survival and attenuated gliosis in HD.